Effect of caffeine on erectile function via up-regulating cavernous cyclic guanosine monophosphate in diabetic rats

Journal of Andrology

Volumn 29, Issue 5, 2008, Pages 586-591

  Yang, Rong ^a   Wang, Jiuling ^a   Chen, Yun ^a   Sun, Zeyu ^a   Wang, Run ^b   Dai, Yutian ^a,c  

^a NANJING UNIVERSITY   (China)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^c THE AFFILIATED DRUM TOWER HOSPITAL OF NANJING UNIVERSITY MEDICAL SCHOOL   (China)

Author keywords

Diabetes mellitus; Erectile dysfunction; NO cGMP pathway

Indexed keywords

CAFFEINE; CYCLIC GMP; GLUCOSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS CAVERNOSUM; DIABETES MELLITUS; DRUG DOSE COMPARISON; DRUG MECHANISM; ERECTILE DYSFUNCTION; GLUCOSE BLOOD LEVEL; LOW DRUG DOSE; MALE; NONHUMAN; PENIS ERECTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; RADIOIMMUNOASSAY; RAT; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT; STREPTOZOCIN DIABETES; TREATMENT DURATION; UPREGULATION;

ANIMALS; CAFFEINE; CYCLIC GMP; DIABETES MELLITUS, EXPERIMENTAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ERECTILE DYSFUNCTION; MALE; NITRIC OXIDE; PENILE ERECTION; PENIS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 52949116001     PISSN: 01963635     EISSN: None     Source Type: Journal    
DOI: 10.2164/jandrol.107.004721     Document Type: Article

References (34)

1. Adebiyi A, Adaikan PG. Effect of caffeine on response of rabbit isolated corpus cavernosum to high K+ solution, noradrenaline and transmural electrical stimulation. Clin Exp Pharmacol Physiol. 2004;31:82-85.
2. Akkus E, Kadioglu A, Esen A, Doran S, Ergen A, Anafarta K, Hattat H. Prevalence and correlates of erectile dysfunction in Turkey: a population-based study. Eur Urol. 2002;41:298-304.
3. Andersson KE, Wagner G. Physiology of penile erection. Physiol Rev. 1995;75:191-236.
4. Apaydin S, Gonen C, Guven H. The probable role of nitric oxide on the relaxations obtained by caffeine and aminophylline in rat uterus. Pharmacol Res. 1998;38:387-392.
5. Berrada S, Kadri N, Mechakra-Tahiri S, Nejjari C. Prevalence of erectile dysfunction and its correlates: a population-based study in Morocco. Int J Impot Res. 2003;15(suppl 1):S3-S7.
6. Bivalacqua TJ, Usta MF, Kendirci M, Pradhan L, Alvarez X, Champion HC, Kadowitz PJ, Hellstrom WJ. Superoxide anion production in the rat penis impairs erectile function in diabetes: influence of in vivo extracellular superoxide dismutase gene therapy. J Sex Med. 2005;2:187-197.
7. Blanco R, Saenz de Tejada I, Goldstein I, Krane RJ, Wotiz HH, Cohen RA. Dysfunctional penile cholinergic nerves in diabetic impotent men. J Urol. 1990;144:278-280.
8. Bredt DS, Snyder SH. Nitric oxide: a physiologic messenger molecule. Annu Rev Biochem. 1994;63:175-195.
9. Chen Y, Dai Y, Wang R. Treatment strategies for diabetic patients suffering from erectile dysfunction. Expert Opin Pharmacother. 2008;9:257-266.
10. Chen Y, Li SX, Yao LS, Wang R, Dai YT. Valsartan treatment reverses erectile dysfunction in diabetic rats. Int J Impot Res. 2007;19:366-370.
11. Corbin JD, Francis SH. Pharmacology of phosphodiesterase-5 inhibitors. Int J Clin Pract. 2002;56:453-459.
12. Diokno AC, Brown MB, Herzog AR. Sexual function in the elderly. Arch Intern Med. 1990;150:197-200.
13. El-Sakka A, Yen TS, Lin CS, Lue TF. Traumatic arteriogenic erectile dysfunction: a rat model. Int J Impot Res. 2001;13:162-171.
14. Kandeel FR, Koussa VK, Swerdloff RS. Male sexual function and its disorders: physiology, pathophysiology, clinical investigation, and treatment. Endocr Rev. 2001;22:342-388.
15. Lindaman BA, Hinkhouse MM, Conklin JL, Cullen JJ. The effect of phosphodiesterase inhibition on gallbladder motility in vitro. J Surg Res. 2002;105:102-108.
16. Lopez-Garcia E, van Dam RM, Qi L, Hu FB. Coffee consumption and markers of inflammation and endothelial dysfunction in healthy and diabetic women. Am J Clin Nutr. 2006;84:888-893.
17. Moore CR, Wang R. Pathophysiology and treatment of diabetic erectile dysfunction. Asian J Androl. 2006;8:675-684.
18. Moreland RB, Hsieh G, Nakane M, Brioni JD. The biochemical and neurologic basis for the treatment of male erectile dysfunction. J Pharmacol Exp Ther. 2001;296:225-234.
19. Musicki B, Burnett AL. Endothelial dysfunction in diabetic erectile dysfunction. Int J Impot Res. 2007;19:129-138.
20. Nicolosi A, Moreira ED Jr, Shirai M, Bin Mohd Tambi MI, Glasser DB. Epidemiology of erectile dysfunction in four countries: cross-national study of the prevalence and correlates of erectile dysfunction. Urology. 2003;61:201-206.
21. Park CS, Ryu SD, Hwang SY. Elevation of intracavernous pressure and NO-cGMP activity by a new herbal formula in penile tissues of aged and diabetic rats. J Ethnopharmacol. 2004;94:85-92.
22. Park S, Jang JS, Hong SM. Long-term consumption of caffeine improves glucose homeostasis by enhancing insulinotropic action through islet insulin/insulin-like growth factor 1 signaling in diabetic rats. Metabolism. 2007;56:599-607.
23. Quek KF, Sallam AA, Ng CH, Chua CB. Prevalence of sexual problems and Its association with social, psychological and physical factors among men in a Malaysian population: a cross-sectional study. J Sex Med. 2008;5(1):70-76.
24. Rathmann W, Giani G. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27: 2568-2569.
25. Rehman J, Chenven E, Brink P, Peterson B, Walcott B, Wen YP, Melman A, Christ G. Diminished neurogenic but not pharmacological erections in the 2- to 3-month experimentally diabetic F-344 rat. Am J Physiol. 1997;272:H1960-H1971.
26. Richardson D, Vinik A. Etiology and treatment of erectile failure in diabetes mellitus. Curr Diab Rep. 2002;2:501-509.
27. Saenz de Tejada I, Goldstein I, Azadzoi K, Krane RJ, Cohen RA. Impaired neurogenic and endothelium-mediated relaxation of penile smooth muscle from diabetic men with impotence. N Engl J Med. 1989; 320:1025-1030.
28. Sasaki H, Yamasaki H, Ogawa K, Nanjo K, Kawamori R, Iwamoto Y, Katayama S, Shirai M. Prevalence and risk factors for erectile dysfunction in Japanese diabetics. Diabetes Res Clin Pract. 2005;70:81-89.
29. Seidler M, Uckert S, Waldkirch E, Stief CG, Oelke M, Tsikas D, Sohn M, Jonas U. In vitro effects of a novel class of nitric oxide (NO) donating compounds on isolated human erectile tissue. Eur Urol. 2002;42:523-528.
30. Sekiguchi F, Miyake Y, Kashimoto T, Sunano S. Unaltered caffeine-induced relaxation in the aorta of stroke-prone spontaneously hypertensive rats (SHRSP). J Smooth Muscle Res. 2002;38:11-22.
31. Shiri R, Koskimaki J, Hakama M, Hakkinen J, Huhtala H, Tammela TL, Auvinen A. Effect of life-style factors on incidence of erectile dysfunction. Int J Impot Res. 2004;16:389-394.
32. Smith PF, Smith A, Miners J, McNeil JAP. Report From the Expert Working Group on the Safety Aspects of Dietary Caffeine. Canberra: Australian New Zealand Food Authority; 2000.
33. Watanabe C, Yamamoto H, Hirano K, Kobayashi S, Kanaide H. Mechanisms of caffeine-induced contraction and relaxation of rat aortic smooth muscle. J Physiol. 1992;456:193-213.
34. Yi CR, Wei ZQ, Deng XL, Sun ZY, Li XR, Tian CG. Effects of coffee and caffeine on bladder dysfunction in streptozotocin-induced diabetic rats. Acta Pharmacol Sin. 2006;27:1037-1043.